Circulating contact-pathway-activating microparticles together with factors IXa and XIa induce spontaneous clotting in plasma of hematology and cardiologic patients

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Lipets, Elena ^a,b   Vlasova, Olga ^c   Urnova, Evdokiya ^d   Margolin, Oleg ^d   Soloveva, Anna ^d   Ostapushchenko, Olga ^d   Andersen, John ^e   Ataullakhanov, Fazoil ^a,b,c,d,f   Panteleev, Mikhail ^a,b,c,d,f  

^a Federal Research and Clinical Center of Pediatric Hematology   (Russian Federation)

^b HemaCore LLC   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f CENTER FOR THEORETICAL PROBLEMS OF PHYSICOCHEMICAL PHARMACOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 9A; BLOOD CLOTTING INHIBITOR; PHOSPHOLIPID; THROMBOPLASTIN; TISSUE FACTOR INHIBITOR 7AI; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ARTICLE; BLOOD CLOTTING; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HEART INFARCTION; HEMOLYTIC ANEMIA; HUMAN; IN VITRO STUDY; LIPID MEMBRANE; PILOT STUDY; SPONTANEOUS CLOTTING; THROMBOCYTE FREE PLASMA;

ACUTE DISEASE; ANEMIA, HEMOLYTIC; BLOOD COAGULATION; CELL-DERIVED MICROPARTICLES; FACTOR IXA; FACTOR XIA; FEMALE; HUMANS; LEUKEMIA; MALE; MYOCARDIAL INFARCTION;

EID: 84900325944     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087692     Document Type: Article

References (31)

1. Undas A, Slowik A, Gissel M, Mann KG, Butenas S (2011) Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events. Thromb Res 128: e62-e66.
2. Zabczyk M, Butenas S, Plicner D, Fijorek K, Sadowski J, Undas A (2012) Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients. Blood Coagul Fibrinolysis 23: 189-194.
3. Undas A, Slowik A, Gissel M, Mann KG, Butenas S (2012) Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular events. Eur J Clin Invest 42: 123-129. 10.1111/j.1365-2362.2011.02565.x [doi].
4. Luszczak J, Undas A, Gissel M, Olszowska M, Butenas S (2011) Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation. Blood Coagul Fibrinolysis 22: 473-479. 10.1097/MBC.0b013e328346c2bb [doi].
5. Zabczyk M, Butenas S, Palka I, Nessler J, Undas A (2010) Active tissue factor and activated factor XI in circulating blood of patients with systolic heart failure due to ischemic cardiomyopathy. Pol Arch Med Wewn 120: 334-340.
6. Miller GJ, Esnouf MP, Burgess AI, Cooper JA, Mitchell JP (1997) Risk of coronary heart disease and activation of factor XII in middle-aged men. Arterioscler Thromb Vasc Biol 17: 2103-2106. (Pubitemid 28057114)
7. Dvorak HF, Van DL, Bitzer AM, Dvorak AM, Anderson D, Harvey VS, Bach R, Davis GL, DeWolf W, Carvalho AC (1983) Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 43: 4434-4442. (Pubitemid 13041884)
8. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101: 841-843. (Pubitemid 30117876)
9. van Beers EJ, Schaap MC, Berckmans RJ, Nieuwland R, Sturk A, van Doormaal FF, Meijers JC, Biemond BJ (2009) Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 94: 1513-1519.
10. Westerman MP, Cole ER, Wu K (1984) The effect of spicules obtained from sickle red cells on clotting activity. Br J Haematol 56: 557-562. (Pubitemid 14128132)
11. Chironi GN, Boulanger CM, Simon A, gnat-George F, Freyssinet JM, Tedgui A (2009) Endothelial microparticles in diseases. Cell Tissue Res 335: 143-151.
12. Herbert JM, Savi P, Laplace MC, Lale A, Dol F, Dumas A, Labit C, Minty A (1993) IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett 328: 268-270. (Pubitemid 23238101)
13. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM (1993) C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82: 513-520. (Pubitemid 23206115)
14. Panteleev MA, Ovanesov MV, Kireev DA, Shibeko AM, Sinauridze EI, Ananyeva NM, Butylin AA, Saenko EL, Ataullakhanov FI (2006) Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. Biophys J 90: 1489-1500. S0006-3495(06)72340-2 [pii];10.1529/biophysj.105.069062 [doi].
15. Ovanesov MV, Krasotkina JV, Ul'yanova LI, Abushinova KV, Plyushch OP, Domogatskii SP, Vorob'ev AI, Ataullakhanov FI (2002) Hemophilia A and B are associated with abnormal spatial dynamics of clot growth. Biochim Biophys Acta 1572: 45-57. S0304416502002787 [pii].
16. Andersen JF, Ding XD, Balfour C, Shokhireva TK, Champagne DE, Walker FA, Montfort WR (2000) Kinetics and equilibria in ligand binding by nitrophorins 1-4: evidence for stabilization of a nitric oxide-ferriheme complex through a ligand-induced conformational trap. Biochemistry 39: 10118-10131. bi000766b [pii].
17. Fadeeva OA, Panteleev MA, Karamzin SS, Balandina AN, Smirnov IV, Ataullakhanov FI (2010) Thromboplastin immobilized on polystyrene surface exhibits kinetic characteristics close to those for the native protein and activates in vitro blood coagulation similarly to thromboplastin on fibroblasts. Biochemistry (Mosc) 75: 734-743.
18. Arnljots B, Ezban M, Hedner U (1997) Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIa. J Vasc Surg 25: 341-346. (Pubitemid 27102658)
19. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, Sturk A (2001) Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 85: 810-820. (Pubitemid 32421813)
20. Undas A, Slowik A, Gissel M, Mann KG, Butenas S (2011) Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events. Thromb Res 128: e62-e66.
21. Zabczyk M, Butenas S, Plicner D, Fijorek K, Sadowski J, Undas A (2012) Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients. Blood Coagul Fibrinolysis 23: 189-194.
22. Lindley CM, Sawyer WT, Macik BG, Lusher J, Harrison JF, Baird-Cox K, Birch K, Glazer S, Roberts HR (1994) Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clin Pharmacol Ther 55: 638-648. (Pubitemid 24212264)
23. Pieters J, Lindhout T, Willems G (1990) Heparin-stimulated inhibition of factor IXa generation and factor IXa neutralization in plasma. Blood 76: 549-554. (Pubitemid 20251822)
24. Rosberg JS, McKenna PW, Rosberg RD (2012) Inhibition of Human Factor IX, by Human Antithrombin. The Journal of Biological Chemistry 250: 8883-8888.
25. Panteleev MA, Balandina AN, Lipets EN, Ovanesov MV, Ataullakhanov FI (2010) Task-oriented modular decomposition of biological networks: trigger mechanism in blood coagulation. Biophys J 98: 1751-1761.
26. Back J, Sanchez J, Elgue G, Ekdahl KN, Nilsson B (2010) Activated human platelets induce factor XIIa-mediated contact activation. Biochem Biophys Res Commun 391: 11-17.
27. Berckmans RJ, Nieuwland R, Boing AN, Romijn FP, Hack CE, Sturk A (2001) Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85: 639-646. (Pubitemid 32293699)
28. Van Der Meijden PE, Van SM, Van OR, Renne T, ten CH, Spronk HM (2012) Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. J Thromb Haemost 10: 1355-1362. 10.1111/j.1538-7836.2012.04758.x [doi].
29. Minnema MC, Peters RJ, de WR, Lubbers YP, Barzegar S, Bauer KA, Rosenberg RD, Hack CE, ten CH (2000) Activation of clotting factors XI and IX in patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol 20: 2489-2493.
30. Lacroix R, Dignat-George F (2012) Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Thromb Res 129 Suppl 2 : S27-S29. S0049-3848(12)00073-4 [pii]; 10.1016/j.thromres.2012.02.025 [doi].
31. Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J, gnat-George F (2012) Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 10: 437-446.